Clinical Roundup Rare pancreatic cancer shows strong response to immunotherapy July 03, 2025Vol.51 No.26
Clinical Roundup Scientists wipe out aggressive brain cancer tumors by targeting cellular “motors” July 03, 2025Vol.51 No.26
Drugs & Targets FDA grants accelerated approval to Zegfrovy for NSCLC with EGFR exon20ins July 03, 2025Vol.51 No.26
Drugs & Targets FDA grants accelerated approval to linvoseltamab-gcpt for r/r MM July 03, 2025Vol.51 No.26
Drugs & Targets REMS for currently approved BCMA- and CD19-directed autologous CAR T-cell immunotherapies eliminated July 03, 2025Vol.51 No.26
Capitol Hill At House hearing, Democrats clash with RFK Jr. over “radical obstruction of congressional oversight,” vaccine policiesRep. Lori Trahan: “People are going to die” June 27, 2025Vol.51 No.25By Claire Marie Porter
Guest Editorial Building cancer care resilience through international observerships: Lessons from Ukraine June 27, 2025Vol.51 No.25By Nataliya Kovalchuk, Andriy Beznosenko, Vitaliy Y. Poylin, Rostyslav Semikov, Arman Kacharian, Douglas Davis, Nataliya Uboha, Natalka Suchowerska, Viktor Iakovenko, Jacqueline Hart, Mark Poznansky, Darya Kizub and Nelya Melnitchouk
Trials & Tribulations As cancer patients use AI chatbots, dangers lurk—but new safeguards can help June 27, 2025Vol.51 No.25By Ghulam Rasool, Brian D. Gonzalez and Katherine Chung-Bridges
